Access
To read this story in full you will need to login or make a payment (see right).
Scientific Correspondence
Nature 400, 723-724 (19 August 1999) | doi:10.1038/23382
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Faculty Positions in Cancer, Cardiovascular and Metabolic Diseases, Immunology
- Institute de Recherches Cliniques de Montreal
- Montreal, Quebec, Canada
Endowed Professorship
- Washington University School of Medicine in St. Louis
- St. Louis, MO 63110 United States
Chemokine control of HIV-1 infection
Mario Mellado1, José Miguel Rodríguez-Frade, Antonio J. Vila-Coro1, Ana Martín de Ana & Carlos Martínez-A.
Abstract
Chemokines are proinflammatory cytokines that attract and activate specific types of leukocyte1. There are two main chemokine families, based on the position of the first two cysteine residues: the CC and the CXC chemokines1. Chemokines mediate their effects through interactions with seven-transmembrane-spanning glyco-protein receptors coupled to a G-protein signalling pathway1. Chemokine receptors normally undergo a ligand-mediated homodimerization process, which is required for Ca2+ flux and chemotaxis2. Here we show that in the chemokine response it is possible for heterodimerization, rather than homodimerization, to occur between a mutant form of the CCR2 receptor (the CCR2V64I receptor), which helps to delay the development of AIDS in HIV-1-infected individuals, and the CCR5 or CXCR4 chemokine receptor, which are used by HIV to gain entry into cells. These results may explain why AIDS takes longer to develop in HIV-1-infected individuals carrying the CCR2V64I mutation3.
To read this story in full you will need to login or make a payment (see right).

